ARCHIVES

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

This article is from The Cancer Letter archive.

Vol. 13 No. 39 | October 9, 1987

Download PDF Visit The Full Archive

Related Articles

NCI Bioinformatics After Kenneth Buetow: Varmus Launches Fundamental Redesign

January 6, 2012

Other Concepts Approves By DCE Board Last Week

June 20, 1986

Meharry, Vanderbilt Win Grant For Research Collaboration.

March 30, 2001

HHS News: Shalala Appoints Group On Genetic Testing

June 25, 1999

Senate committee approves $1.1 billion increase for NIH.

October 1, 2004

In Brief: Terms Expire Next Year For Six NCAB Members, One On Panel; Fraumeni Preventative Oncology President

October 16, 1981